Munsie Jeffrey A Insider Trades

Insider Trading History

Track insider trading activity for Munsie Jeffrey A. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Mar 06, 2023 Sale (Tender)Reported as Tender on SEC Form 4.
$307k 38,350 shares
$8.00
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $0 0 shares
Last Trade
Mar 06, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.13M 243,979 shares
$8.71
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $737k 88,049 shares
Last Trade
Feb 15, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$31.4k 3,762 shares
$8.34
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $768k 91,811 shares
Last Trade
Jan 30, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$70.9k 8,493 shares
$8.35
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $840k 100,304 shares
Last Trade
Jan 06, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$21k 2,893 shares
$7.25
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $864k 103,197 shares
Last Trade
Feb 14, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$11.6k 3,762 shares
$3.09
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $895k 106,959 shares
Last Trade
Jan 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$184k 63,700 shares
$2.89
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $362k 43,259 shares
Last Trade
Jan 05, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.26k 2,894 shares
$3.20
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $386k 46,153 shares
Last Trade
Feb 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$27.5k 3,763 shares
$7.32
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $434k 51,850 shares
Last Trade
Jan 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$961k 73,550 shares
$13.07
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $355k 42,430 shares
Last Trade
Feb 14, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$768k 70,646 shares
$10.87
$8.37
Concert Pharmaceuticals
Concert Pharmaceuticals CNCE
Chief Legal Officer
Holding Value $837k 100,000 shares
Last Trade
Sep 26, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$987k 100,000 shares
$9.87
$8.37
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
General Counsel
Holding Value $682k 45,000 shares
Last Trade
Dec 11, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$166k 45,000 shares
$3.69
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
General Counsel
Holding Value $682k 45,000 shares
Last Trade
Feb 15, 2018 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$430k 45,000 shares
$9.55
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
General Counsel
Holding Value $8.33M 550,000 shares
Last Trade
Jun 06, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.09M 550,000 shares
$12.89
$15.14
Merrimack Pharmaceuticals
Merrimack Pharmaceuticals MACK
General Counsel
Holding Value $0 0 shares
Last Trade
Mar 31, 2017 Sale
$7.43M 271,118 shares
$27.39
$15.14

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up